Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Fadilah NIM, Isa ILM, Zaman WSWK, Tabata Y, Fauzi MB
Individuals who already receive GLP-1 medications through their existing Medicare prescription drug coverage or are eligible for separate Medicare GLP-1 coverage, Medicare Part D, are excluded
Phase 2 Clinical Trials Results of NA-931, a Novel Quadruple IGF-1-1, GLP-1, GIP, and Glucagon Receptor Agonist Reduces Body Weight without Muscle Loss LLOYD L
Engineering antibody and protein therapeutics to cross the blood-brain barrier
& Hunger, J
US$ 20.36
US$ 26.89
US$ 23.10
